Phase I/II Clinical Study to Evaluate VB15010 Tablets in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Pancreatic Cancer
Related studies linked through entity extraction aliases.
CAR-NK Cells (CL-NK-001) in Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE1
The Influence of Secretin Stimulated Pancreatic Secretion on ctDNA Expression in Patients With Pancreatic Ductal Adenocarcinoma: The Role of Biomarkers in Determining the Prognosis of Pancreatic Ductal Adenocarcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
ToPanc Trial: Survival After Total Versus Partial Pancreaticoduodenectomy for Adenocarcinoma of the Pancreatic Head, Distal Cholangiocarcinoma, and Ampullary Cancer
- Status
- RECRUITING
- Phase
- NA
Proteomic Analysis of Patients Undergoing Bariatric Surgery
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Maintenance Chemotherapy With S-1 vs. Observation After Adjuvant Therapy for Resected Pancreatic Cancer With High Risk of Recurrence/Metastasis
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
Role of Exosomes in Pancreatic Cancer Progression
- Status
- RECRUITING
- Phase
- N/A
Adebrelimab Combined With Irinotecan Liposomal (II), Oxaliplatin, and 5-FU/LV Conversion Therapy for Locally Advanced Pancreatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Resectable Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Alpha Radiation Emitters Device (DaRT) for the Treatment of Locally Advanced Pancreatic Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Validation of Joint-AI in Diagnosing Pancreatic Solid Lesions
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Expanded Access Program (EAP) Designed to Provide Access to Botensilimab and Balstilimab Before Regulatory Approval
- Status
- AVAILABLE
- Phase
- N/A
Onvansertib in Combination With NALIRIFOX for First Line Treatment of Advanced Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Oral Immunonutrition Therapy to Reduce Acute Toxicity After Neoadjuvant Chemoradiotherapy Pancreatic Cancer Patients
- Status
- RECRUITING
- Phase
- NA
Target-specific immunoPET Imaging of Digestive System Carcinoma
- Status
- RECRUITING
- Phase
- NA
Observational Copenhagen Pancreatic Cancer Study
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Spanish Registry of Digestive Tumours RETUD
- Status
- RECRUITING
- Phase
- N/A
Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Second-line Irinotecan Liposome Combination Regimen for Irinotecan-treated Pancreatic Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2